First Time Loading...

Avidity Biosciences Inc
NASDAQ:RNA

Watchlist Manager
Avidity Biosciences Inc Logo
Avidity Biosciences Inc
NASDAQ:RNA
Watchlist
Price: 25.8 USD 6.92% Market Closed
Updated: May 2, 2024

Wall Street
Price Targets

RNA Price Targets Summary
Avidity Biosciences Inc

Wall Street analysts forecast RNA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RNA is 47.65 USD with a low forecast of 33.33 USD and a high forecast of 74.55 USD.

Lowest
Price Target
33.33 USD
29% Upside
Average
Price Target
47.65 USD
85% Upside
Highest
Price Target
74.55 USD
189% Upside
Avidity Biosciences Inc Competitors:
Price Targets
AVCT
Avacta Group PLC
101% Upside
QNCX
Quince Therapeutics Inc
202% Upside
1530
3SBio Inc
16% Upside
TGTX
TG Therapeutics Inc
95% Upside
688373
Shanghai MicuRx Pharmaceutical Co Ltd
71% Upside
PRLD
Prelude Therapeutics Inc
59% Upside
HARP
Harpoon Therapeutics Inc
8% Upside
MGX
Metagenomi Inc
226% Upside

Revenue
Forecast

Revenue Estimate
Avidity Biosciences Inc

For the last 4 years the compound annual growth rate for Avidity Biosciences Inc's revenue is 42%. The projected CAGR for the next 3 years is 108%.

42%
Past Growth
108%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Avidity Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
Avidity Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-41%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RNA's stock price target?
Price Target
47.65 USD

According to Wall Street analysts, the average 1-year price target for RNA is 47.65 USD with a low forecast of 33.33 USD and a high forecast of 74.55 USD.

What is Avidity Biosciences Inc's Revenue forecast?
Projected CAGR
108%

For the last 4 years the compound annual growth rate for Avidity Biosciences Inc's revenue is 42%. The projected CAGR for the next 3 years is 108%.